Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

34.61
Delayed Data
As of May 27
 +0.18 / +0.52%
Today’s Change
28.25
Today|||52-Week Range
36.46
+7.22%
Year-to-Date
Better Buy: Novavax, Inc. vs. Pfizer Inc.
May 30 / MotleyFool.com - Paid Partner Content
Bet You Can't Guess Which of These 10 Big Pharma Names Has the Largest Late-Stage Pip...
May 28 / MotleyFool.com - Paid Partner Content
Biogen & AbbVie's Multiple Sclerosis Drug Gets FDA Nod
May 30 / Zacks.com - Paid Partner Content
Portola Pharmaceuticals: Does New Data Get It Back on Track?
May 28 / MotleyFool.com - Paid Partner Content
Intercept's (ICPT) Liver Dug Ocaliva Approved by the FDA
May 30 / Zacks.com - Paid Partner Content
This New Data Could Push Exelixis' Cabometyx Over $1 Billion in Peak Annual Sales
May 27 / MotleyFool.com - Paid Partner Content
These 5 Big Pharma Stocks Are Ridiculously Cheap
May 30 / MotleyFool.com - Paid Partner Content
3 Small Biotechs That Look Very Healthy
May 27 / TheStreet.com - Paid Partner Content
Relypsa Up on CRL for AstraZeneca Hyperkalemia Drug
May 30 / Zacks.com - Paid Partner Content
Interested in Medivation? Take a Number!
May 27 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close34.43
Today’s open34.38
Day’s range34.38 - 34.75
Volume20,464,005
Average volume (3 months)43,589,603
Market cap$209.9B
Dividend yield3.47%
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+9.83%
Earnings growth (next 5 years)+6.80%
Revenue growth (last year)-1.52%
P/E ratio28.4
Price/Sales4.13
Price/Book3.30

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.03-0.04%
AGNPRAAllergan plc+9.50+1.14%
MRKMerck+0.09+0.16%
BMYBristol-Myers Squibb+0.58+0.82%
Data as of 4:03pm ET, 05/27/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.61
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs